Skip to content

Role of homoeopathic medicines using LM potency in chronic anal fissure

Role of Homoeopathic Medicines using LM potency in management of chronic anal fissure in age group of 20-60 years assessed by realise score - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079674
Enrollment
40
Registered
2025-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K601- Chronic anal fissure

Interventions

Intervention1: HOMOEOPATHIC MEDICINES: POTENCY LM POTENCY DOSE AS PER NEED OF CASE FREQENCY AS PER NEED OF CASE ROUTE OF ADMINISTRATION ORAL DURATION OF TREATMENT UPTO 6 MONTHS AS PER NEED OF CASE Co

Sponsors

DR NANCY CHETANBHAI PATEL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The cases will diagnose according icd 11 Age group 20 TO 60 years Consent Participants willing to provide informed consent to participate in study Patients who have complaints of chronic anal fissure more than 6 weeks The REALISE score is 4 21

Exclusion criteria

Exclusion criteria: Hemorrhoids Fistula ano rectal or Perianal Abscess Crohns disease Ulcerative colitis Diverticulosis Anal or rectal Malignancy colon malignancy Tuberculosis syphilis Hepatitis B Multiple fissures irritable bowel disease AIDs no any major organic pathology Previous anorectal operations rectal prolapsed polyp in rectum Congenital anomalies of the anal canal Patients inability to comply with study protocol(psychiatric disease) or mental behavioural disorders neurodevelopmental disease Pregnancy and lactating mother Patients who are taking any mode of treatment like Allopathy Homoeopathy Ayurvedic etc

Design outcomes

Primary

MeasureTime frame
REALISE SCORE TO ASSESS REDUCTION IN SYMPTOMS OF CHRONIC ANAL FISSURETimepoint: SCORE WILL BE ASSESSED AT BASELINE AND AT END OF TRERATMENT

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDR NANCY CHETANBHAI PATEL

SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE

ravalmayank3@gmail.com9979133069

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026